Tudor Investment Corp
HUMA icon

Tudor Investment Corp’s Humacyte HUMA Stock Holding History

Tudor Investment Corp’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46K Buy
+12,300
New +$12.8K ﹤0.01% 3512
2024
Q3 		– Sell
-12,151
Closed -$58.3K – 2887
2024
Q2 		$58.3K Buy
+12,151
New +$63.2K ﹤0.01% 2227
2021
Q3 		– Sell
-402,795
Closed -$4.1M – 2607
2021
Q2 		$4.1M Sell
402,795
-140,303
-26% -$1.45M 0.08% 292
2021
Q1 		$5.88M Hold
543,098
– – 0.12% 149
2020
Q4 		$5.52M Buy
+543,098
New +$5.38M 0.16% 116

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Tudor Investment Corp's HUMA Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Humacyte (HUMA) in Q1 2026: 12,300 shares worth $7.46K. The stake represents ﹤0.01% of the portfolio and ranks #3512 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in HUMA as recently as Q2 2024.

Tudor Investment Corp first reported a position in HUMA in Q4 2020 and has held it in 5 quarters since. The position peaked at $5.88M in Q1 2021. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Tudor Investment Corp held 12,300 shares of Humacyte worth $7.46K as of Q1 2026.
  • Humacyte was a new Tudor Investment Corp position in Q1 2026.
  • Humacyte made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #3512 holding.
  • Tudor Investment Corp first reported a position in Humacyte in Q4 2020 and has held it in 5 quarters since.
  • Tudor Investment Corp's Humacyte position peaked at $5.88M in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.